2016

  1. Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study

  2. Ustekinumab in CD safety

  3. Treatment of CD with an IgG4-Guided Exclusion Diet

  4. Ulcerative Colitis Remission Status After Induction With Mesalazine Predicts Maintenance Outcomes: theMOMENTUM Trial

  5. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis

  6. Tonsillectomy and the risk of IBD

  7. Identification of Environmental Factors Associated with Inflammatory Bowel Disease in a Southwestern Highland Region of China: A Nested Case-Control Study

  8. Association between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-Analysis

  9. Association between physical activity and IBD